These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
by 22.7% due to a $1.39B acquired IPRD charge, while legacy drugs Revlimid and Sprycel fell 55% and 60% respectively with generic pomalidomide entry expected in Q1 2026. FedEx ( FDX ) beat Q2 FY2026 adjusted EPS estimates by over 17% at $4.82 with a planned Freight spin-off targeted for June 1, 2026, and raised full-year guidance to $17.80-$19.00 adjusted EPS. Ralph Lauren ( RL ) delivered Q4 revenue of $2.406B beating estimates by 4.16% with EPS of $6.22 topping expectations by 7.10%, plus 22.4% Asia revenue growth with China up over 30% for the second straight quarter. A death cross technical signal has formed for all three stocks, but Bristol Myers Squibb faces genuine fundamental headwinds from legacy drug obsolescence and pipeline binary risks, while FedEx and Ralph Lauren show strong recent earnings beats and positive guidance despite the technical breakdown reflecting broader market volatility rather than company-specific deterioration. A recent study identified one single
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb Tests New Protein Degradation Cancer Drug In Humans [Yahoo! Finance]Yahoo! Finance
- BioIVT to Showcase ADME-Tox and NAMs Expertise at Spring 2026 Industry Events [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026Business Wire
- Don't Miss This 14% Yield And This Pharma Value Stock [Seeking Alpha]Seeking Alpha
- Bristol-Myers Squibb: The Boring Dividend Stock I'd Happily Hold Through Any Crash [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- BMY's page on the SEC website